The optimal oral dose selection of ibandronate in Japanese patients with osteoporosis based on pharmacokinetic and pharmacodynamic properties.
about
Dose-Effectiveness Relationships Determining the Efficacy of Ibandronate for Management of Osteoporosis: A Meta-Analysis.Clinical efficacy and safety of monthly oral ibandronate 100 mg versus monthly intravenous ibandronate 1 mg in Japanese patients with primary osteoporosis.Monthly oral ibandronate 100 mg is as effective as monthly intravenous ibandronate 1 mg in patients with various pathologies in the MOVEST study.
P2860
The optimal oral dose selection of ibandronate in Japanese patients with osteoporosis based on pharmacokinetic and pharmacodynamic properties.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The optimal oral dose selectio ...... nd pharmacodynamic properties.
@ast
The optimal oral dose selectio ...... nd pharmacodynamic properties.
@en
type
label
The optimal oral dose selectio ...... nd pharmacodynamic properties.
@ast
The optimal oral dose selectio ...... nd pharmacodynamic properties.
@en
prefLabel
The optimal oral dose selectio ...... nd pharmacodynamic properties.
@ast
The optimal oral dose selectio ...... nd pharmacodynamic properties.
@en
P2093
P2860
P1476
The optimal oral dose selectio ...... nd pharmacodynamic properties.
@en
P2093
Junko Hashimoto
Kiyohiko Nakai
Masato Tobinai
Satofumi Iida
Takehiko Kawanishi
P2860
P2888
P304
P356
10.1007/S13318-014-0242-5
P577
2014-12-05T00:00:00Z